Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emergent BioSolutions Inc. Common Stock
(NY:
EBS
)
9.720
+0.220 (+2.32%)
Official Closing Price
Updated: 7:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent BioSolutions Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
February 12, 2025
Via
Benzinga
Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
February 07, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
The Analyst Verdict: Emergent BioSolutions In The Eyes Of 4 Experts
January 21, 2025
Via
Benzinga
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
January 16, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
January 14, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola
January 13, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
January 08, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
January 08, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Why Emergent BioSolutions Stock Blasted Higher Today
December 30, 2024
Via
The Motley Fool
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
December 30, 2024
Via
Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
December 30, 2024
Via
Benzinga
Exposures
Fossil Fuels
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
December 30, 2024
Via
Benzinga
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
December 30, 2024
Via
Benzinga
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
December 16, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions
December 09, 2024
UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International...
Via
Benzinga
Why Emergent BioSciences Stock Plummeted Today
December 03, 2024
Via
The Motley Fool
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement
November 22, 2024
Via
Benzinga
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
November 18, 2024
The week kicks off amidst significant market movements shaped by geopolitical and policy developments.
Via
Talk Markets
Topics
Stocks / Equities
After Trump's Win, It's Time To Take Profits On Gold
November 11, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise
November 07, 2024
The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates.
Via
Benzinga
Topics
Death
Exposures
Death
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
November 07, 2024
Emergent BioSolutions stock rises on mixed Q3 results, improved 2024 guidance, and news of a new trial for mpox treatment in Africa led by the CDC.
Via
Benzinga
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
November 07, 2024
Via
Benzinga
Exposures
Fossil Fuels
Gold Gains 1%; Halliburton Posts Weak Q3 Results
November 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 07, 2024
Via
Benzinga
HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday
November 07, 2024
Via
Benzinga
The Post-Trump Victory Trade
November 07, 2024
The Trump Trade.
Via
Benzinga
Topics
Government
Exposures
Political
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 07, 2024
Via
Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
November 07, 2024
Via
Benzinga
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
November 07, 2024
EBS earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
November 06, 2024
From
Emergent BioSolutions
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.